Diagnostic and therapeutic management algorithm for biliary complications in living liver donors.

biliary complications hepaticojejunostomy living donor hepatectomy living donor liver transplantation percutaneous transhepatic biliary tract drainage

Journal

Transplant international : official journal of the European Society for Organ Transplantation
ISSN: 1432-2277
Titre abrégé: Transpl Int
Pays: Switzerland
ID NLM: 8908516

Informations de publication

Date de publication:
Nov 2021
Historique:
revised: 01 09 2021
received: 19 02 2021
accepted: 05 09 2021
pubmed: 13 9 2021
medline: 15 12 2021
entrez: 12 9 2021
Statut: ppublish

Résumé

This study aimed to demonstrate the efficacy of our diagnostic and therapeutic management algorithm and catheter-assisted (percutaneous transhepatic biliary tract drainage [PTBD] or transanastomotic feeding tube) hepaticojejunostomy (HJ) procedures in living liver donors (LLDs) with biliary complications. Living donor hepatectomy (LDH) was performed between September 2005 and April 2021 in 2 489 LLDs. Biliary complications developed in 220 LLDs (8.8%), 136 of which were male, and the median age was 29 (interquartile range [IQR]: 12) years. Endoscopic sphincterotomy ± stenting was performed in 132 LLDs, which was unsuccessful in 9 LLDs and required HJ. Overall, 142 LLDs underwent interventional radiologic procedures. Fifteen LLDs with biliary complications underwent HJ (PTBD catheter = 6 and transanastomotic feeding tube = 9) at a median of 44 days (IQR: 82). Following HJ, 14 LLDs did not have any complications throughout the median follow-up period of 1619 days (IQR: 1454). However, percutaneous dilation for HJ anastomotic stricture was performed in one patient. Biliary complications are very common following LDH; therefore, surgeons in the field should have a low threshold to perform HJ for biliary complications that persist after other treatments. Our catheter-assisted HJ techniques demonstrated a high success rate and aided HJ in a hostile abdomen during revisional surgery.

Identifiants

pubmed: 34510566
doi: 10.1111/tri.14104
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2226-2237

Informations de copyright

© 2021 Steunstichting ESOT. Published by John Wiley & Sons Ltd.

Références

Akbulut S, Yilmaz S. Liver transplantation in Turkey: historical review and future perspectives. Transplant Rev (Orlando) 2015; 29: 161.
Shaji Mathew J, Manikandan K, Santosh Kumar KY, et al. Biliary complications among live donors following live donor liver transplantation. Surgeon 2018; 16: 214.
Braun HJ, Ascher NL, Roll GR, Roberts JP. Biliary complications following living donor hepatectomy. Transplant Rev (Orlando) 2016; 30: 247.
Nagano Y, Togo S, Tanaka K, et al. Risk factors and management of bile leakage after hepatic resection. World J Surg 2003; 27: 695.
Koch M, Garden OJ, Padbury R, et al. Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery 2011; 149: 680.
Kutluturk K, Akbulut S, Baskiran A, et al. Aborted donor hepatectomy in living donor liver transplantation: lessons learned. S Afr J Surg 2020; 58: 91-100.
Onur A, Akbulut S, Dirican A, Isik B, Yilmaz S. Life-threatening or nearly life-threatening complications in living liver donors. Clin Transplant 2018; 32: e13262.
Dirican A, Baskiran A, Dogan M, et al. Evaluation of potential donors in living donor liver transplantation. Transplant Proc 2015; 47: 1315.
Lee SG. A complete treatment of adult living donor liver transplantation: a review of surgical technique and current challenges to expand indication of patients. Am J Transplant 2015; 15: 17.
Kubota T, Hata K, Sozu T, et al. Impact of donor age on recipient survival in adult-to-adult living-donor liver transplantation. Ann Surg 2018; 267: 1126.
Akbulut S, Sahin TT. Comment on minimally invasive donor hepatectomy for adult living donor liver transplantation. Ann Surg 2020 (Published ahead of print). http://dx.doi.org/10.1097/sla.0000000000004281
Akbulut S, Sahin TT, Yilmaz S. Comment on “A worldwide survey of live liver donor selection policies at 24 centers with a combined experience of 19 009 adult living donor liver transplants”. Transplantation 2021; 105: e18.
Usta S, Ates M, Dirican A, Isik B, Yilmaz S. Outcomes of left-lobe donor hepatectomy for living-donor liver transplantation: a single-center experience. Transplant Proc 2013; 45: 961.
Dirican A, Ara C, Kutluturk K, et al. Donor postoperative biliary complications after living-donor liver transplant. Exp Clin Transplant 2015; 13: 516.
Ozgor D, Dirican A, Ates M, Gönültas F, Ara C, Yilmaz S. Donor complications among 500 living donor liver transplantations at a single center. Transplant Proc 2012; 44: 1604.
Cheah YL, Simpson MA, Pomposelli JJ, Pomfret EA. Incidence of death and potentially life-threatening near-miss events in living donor hepatic lobectomy: a world-wide survey. Liver Transpl 2013; 19: 499.
Akbulut S, Isik B, Karipkiz Y, Yilmaz S. Massive subcutaneous emphysema, pneumoperitoneum, pneumoretroperitoneum, and pneumoscrotum following endoscopic retrograde cholangiopancreatography in a living liver donor. Int J Organ Transplant Med 2018; 9: 132.
Yuan Y, Gotoh M. Biliary complications in living liver donors. Surg Today 2010; 40: 411.
Ghobrial RM, Freise CE, Trotter JF, et al. Donor morbidity after living donation for liver transplantation. Gastroenterology 2008; 135: 468.
Hwang S, Lee SG, Lee YJ, et al. Lessons learned from 1,000 living donor liver transplantations in a single center: how to make living donations safe. Liver Transpl 2006; 12: 920.
Humar A, Ganesh S, Jorgensen D, et al. Adult living donor versus deceased donor liver transplant (LDLT versus DDLT) at a single center. Time to change our paradigm for liver transplant. Ann Surg 2019; 270: 444.
Gorgen A, Goldaracena N, Zhang W, et al. Surgical complications after right hepatectomy for live liver donation: largest single-center western world experience. Semin Liver Dis 2018; 38: 134.
Shio S, Yazumi S, Ogawa K, et al. Biliary complications in donors for living donor liver transplantation. Am J Gastroenterol 2008; 103: 1393.
Hashikura Y, Ichida T, Umeshita K, et al. Japanese Liver Transplantation Society. Donor complications associated with living donor liver transplantation in Japan. Transplantation 2009; 88: 110.
Iida T, Ogura Y, Oike F, et al. Surgery-related morbidity in living donors for liver transplantation. Transplantation 2010; 89: 1276.
Dayangac M, Taner CB, Yaprak O, et al. Utilization of elderly donors in living donor liver transplantation: when more is less? Liver Transpl 2011; 17: 548.
Grewal HP, Thistlewaite JR Jr, Loss GE, et al. Complications in 100 living-liver donors. Ann Surg 1998; 228: 214.
Taketomi A, Morita K, Toshima T, et al. Living donor hepatectomies with procedures to prevent biliary complications. J Am Coll Surg 2010; 211: 456.
Aziz AM, Saleh S, Soliman HE, et al. Evaluation of surgical complications in 204 live liver donors according to the modified clavien classification system. Egypt J Surg 2016; 35: 357.
Kim SH, Kim YK, Lee SD, Lee EC, Park SJ. The impact of a surgical protocol for enhanced recovery on living donor right hepatectomy: a single-center cohort study. Medicine (Baltimore) 2016; 95: e3227.
Azzam A, Uryuhara K, Taka I, Takada Y, Egawa H, Tanaka K. Analysis of complications in hepatic right lobe living donors. Ann Saudi Med 2010; 30: 18.
Kiuchi T, Tanaka K. Liver transplantation from living donors: current status in Japan and safety/long-term results in the donor. Transplant Proc 2003; 35: 1172.
El-Meteini M, Hamza A, Abdalaal A, et al. Biliary complications including single-donor mortality: experience of 207 adult-to-adult living donor liver transplantations with right liver grafts. HPB (Oxford) 2010; 12: 109.

Auteurs

Sezai Yilmaz (S)

Liver Transplant Institute, Faculty of Medicine, Inonu University, Malatya, Turkey.

Sami Akbulut (S)

Liver Transplant Institute, Faculty of Medicine, Inonu University, Malatya, Turkey.

Sertac Usta (S)

Liver Transplant Institute, Faculty of Medicine, Inonu University, Malatya, Turkey.

Oguzhan Ozsay (O)

Liver Transplant Institute, Faculty of Medicine, Inonu University, Malatya, Turkey.

Tevfik Tolga Sahin (TT)

Liver Transplant Institute, Faculty of Medicine, Inonu University, Malatya, Turkey.

Kemal Baris Sarici (KB)

Liver Transplant Institute, Faculty of Medicine, Inonu University, Malatya, Turkey.

Ertugrul Karabulut (E)

Liver Transplant Institute, Faculty of Medicine, Inonu University, Malatya, Turkey.

Adil Baskiran (A)

Liver Transplant Institute, Faculty of Medicine, Inonu University, Malatya, Turkey.

Fatih Gonultas (F)

Liver Transplant Institute, Faculty of Medicine, Inonu University, Malatya, Turkey.

Fatih Ozdemir (F)

Liver Transplant Institute, Faculty of Medicine, Inonu University, Malatya, Turkey.

Veysel Ersan (V)

Liver Transplant Institute, Faculty of Medicine, Inonu University, Malatya, Turkey.

Burak Isik (B)

Liver Transplant Institute, Faculty of Medicine, Inonu University, Malatya, Turkey.

Ramazan Kutlu (R)

Department of Radiology, Faculty of Medicine, Inonu University, Malatya, Turkey.

Abuzer Dirican (A)

Liver Transplant Institute, Faculty of Medicine, Inonu University, Malatya, Turkey.

Murat Harputluoglu (M)

Department of Gastroenterology and Hepatology, Faculty of Medicine, Inonu University, Malatya, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH